Compass Capital Management Inc. Buys 65 Shares of Stryker Co. (NYSE:SYK)

Compass Capital Management Inc. raised its stake in shares of Stryker Co. (NYSE:SYK) by 0.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 185,074 shares of the medical technology company’s stock after purchasing an additional 65 shares during the quarter. Stryker accounts for about 3.9% of Compass Capital Management Inc.’s holdings, making the stock its 15th biggest holding. Compass Capital Management Inc.’s holdings in Stryker were worth $55,422,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of the stock. Penobscot Investment Management Company Inc. lifted its position in Stryker by 2.8% during the fourth quarter. Penobscot Investment Management Company Inc. now owns 40,075 shares of the medical technology company’s stock valued at $12,001,000 after purchasing an additional 1,082 shares during the last quarter. Kestra Private Wealth Services LLC lifted its holdings in shares of Stryker by 16.3% in the 4th quarter. Kestra Private Wealth Services LLC now owns 18,020 shares of the medical technology company’s stock worth $5,396,000 after acquiring an additional 2,527 shares during the last quarter. Ledyard National Bank lifted its holdings in shares of Stryker by 8.8% in the 4th quarter. Ledyard National Bank now owns 1,881 shares of the medical technology company’s stock worth $563,000 after acquiring an additional 152 shares during the last quarter. Choreo LLC lifted its holdings in shares of Stryker by 533.0% in the 4th quarter. Choreo LLC now owns 5,874 shares of the medical technology company’s stock worth $1,759,000 after acquiring an additional 4,946 shares during the last quarter. Finally, McAdam LLC bought a new stake in shares of Stryker in the 4th quarter worth approximately $217,000. 77.09% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Ronda E. Stryker sold 201,146 shares of Stryker stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $342.90, for a total transaction of $68,972,963.40. Following the sale, the director now owns 3,755,128 shares of the company’s stock, valued at approximately $1,287,633,391.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Stryker news, Director Ronda E. Stryker sold 201,146 shares of Stryker stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $342.90, for a total value of $68,972,963.40. Following the sale, the director now owns 3,755,128 shares of the company’s stock, valued at approximately $1,287,633,391.20. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CAO William E. Berry, Jr. sold 7,690 shares of Stryker stock in a transaction that occurred on Thursday, March 7th. The stock was sold at an average price of $358.48, for a total value of $2,756,711.20. Following the completion of the transaction, the chief accounting officer now owns 3,675 shares of the company’s stock, valued at approximately $1,317,414. The disclosure for this sale can be found here. Insiders have sold a total of 212,109 shares of company stock valued at $72,845,768 in the last ninety days. Corporate insiders own 5.50% of the company’s stock.

Stryker Stock Performance

NYSE:SYK traded down $2.37 on Tuesday, hitting $336.50. The stock had a trading volume of 2,459,598 shares, compared to its average volume of 1,301,242. The stock has a market cap of $128.03 billion, a price-to-earnings ratio of 41.09, a price-to-earnings-growth ratio of 2.70 and a beta of 0.89. The company has a quick ratio of 0.97, a current ratio of 1.58 and a debt-to-equity ratio of 0.59. The business’s 50-day simple moving average is $348.68 and its two-hundred day simple moving average is $316.14. Stryker Co. has a 52-week low of $249.98 and a 52-week high of $361.41.

Stryker (NYSE:SYK) last announced its earnings results on Tuesday, January 30th. The medical technology company reported $3.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.27 by $0.19. The business had revenue of $5.82 billion for the quarter, compared to analysts’ expectations of $5.60 billion. Stryker had a return on equity of 22.99% and a net margin of 15.44%. The business’s revenue for the quarter was up 11.8% on a year-over-year basis. During the same period last year, the firm posted $3.00 earnings per share. As a group, research analysts predict that Stryker Co. will post 11.86 earnings per share for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 30th. Stockholders of record on Friday, March 29th will be given a dividend of $0.80 per share. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $3.20 dividend on an annualized basis and a dividend yield of 0.95%. Stryker’s payout ratio is currently 38.79%.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on SYK. Canaccord Genuity Group upgraded shares of Stryker from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $315.00 to $360.00 in a report on Wednesday, January 31st. Royal Bank of Canada lifted their target price on shares of Stryker from $360.00 to $386.00 and gave the stock an “outperform” rating in a research note on Monday, April 15th. Canaccord Genuity Group raised shares of Stryker from a “hold” rating to a “buy” rating and set a $360.00 target price on the stock in a research note on Wednesday, January 31st. Evercore ISI boosted their price objective on shares of Stryker from $340.00 to $370.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Finally, Truist Financial upped their target price on shares of Stryker from $330.00 to $345.00 and gave the stock a “hold” rating in a research report on Wednesday, January 31st. Three research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $340.67.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.